SPRB

SPRUCE BIOSCIENCES, INC. SPRB

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $10.1M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-16.23M

Quarter to Jun 30

Free cash flow

$-22.25M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$116.26M total
AIGH Capital Management LLC
$13.50MNew
ORBIMED ADVISORS LLC
$10.80MNew
BlackRock, Inc.
$10.14M+1009.0%
MILLENNIUM MANAGEMENT LLC
$8.69M+43.9%
AWM Investment Company, Inc.
$7.94MNew
Ikarian Capital, LLC
$6.55M0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$6.44MNew
Alyeska Investment Group, L.P.
$4.41M+58.1%
GEODE CAPITAL MANAGEMENT, LLC
$3.81M+447.4%
ADAR1 Capital Management, LLC
$3.66M+15.6%
Cable Car Capital, LP
$3.24MNew
CITADEL ADVISORS LLC
$2.80M-25.8%
STATE STREET CORP
$2.72M+834.3%
BOOTHBAY FUND MANAGEMENT, LLC
$2.27M0.0%
StemPoint Capital LP
$2.23M+550.8%
Eversept Partners, LP
$2.16MNew
Carlyle Group Inc.
$2.09M0.0%
GOLDMAN SACHS GROUP INC
$1.75M+487.5%
Affinity Asset Advisors, LLC
$1.62MNew
DIADEMA PARTNERS LP
$1.62M+200.0%
Stonepine Capital Management, LLC
$1.55MNew
Point72 Asset Management, L.P.
$1.53MNew
Quinn Opportunity Partners LLC
$1.45M0.0%
UBS Group AG
$1.26M+496.6%
ExodusPoint Capital Management, LP
$1.19M0.0%
See all 65 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/SPRB

Earnings Per Share

13fpro.ai/company/SPRB

Loading ratio trend…

SPRB key financials by period

Reported revenue, net income and operating margin by fiscal year, from SPRUCE BIOSCIENCES, INC.'s annual filings on SEC EDGAR.

SPRUCE BIOSCIENCES, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2024$4.9M$-53.0M—
FY 2023$10.1M$-47.9M—
Source: SPRB filings on SEC EDGAR →

SPRB insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About SPRUCE BIOSCIENCES, INC. (SPRB): stock profile, AI score and financials

SPRUCE BIOSCIENCES, INC. (SPRB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. SPRB is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $10.1m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), SPRUCE BIOSCIENCES, INC. reports net income of $-16.2M, free cash flow of $-22.3M. Top institutional holders of SPRB by reported 13-F value include AIGH Capital Management, ORBIMED ADVISORS, BlackRock, based on the most recent SEC filings. SPRB trades on the Nasdaq exchange and files with the SEC under CIK 1683553. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SPRB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SPRUCE BIOSCIENCES, INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1683553 →